Minimize spillover and maximize breakthrough with BD Horizon RealBlue 780 Reagents
19 Oct 2026Discover the power of BD Horizon RealBlue™ 780 Reagents designed to generate high-resolution data. Experience significantly reduced spillover and background from non-specific monocyte binding compared to PE-Cy7. Available on hundreds of specificities, they are bright and clean, enabling clearer analysis of low-expression markers. This video demonstrates how these advanced reagents accelerate scientific breakthroughs and expand multicolor panel flexibility.
About the company

BD Biosciences
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in nearly 50 countries worldwide.



